Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy.


Journal Article

Full Text

Duke Authors

Cited Authors

  • Califf, RM; Stump, D; Topol, EJ; Mark, DB

Published Date

  • May 1999

Published In

Volume / Issue

  • 137 / 5

Start / End Page

  • S90 - S93

Pubmed Central ID

  • 10220606

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

International Standard Serial Number (ISSN)

  • 0002-8703

Digital Object Identifier (DOI)

  • 10.1016/s0002-8703(99)70438-2


  • eng